|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/00 | |||
| A61P 19/00 | |||
| A61P 9/00 | |||
| A61P 11/00 | |||
| C07K 16/24 |
| (11) | Number of the document | 2280732 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09739607.1 |
| Date of filing the European patent application | 2009-04-28 | |
| (97) | Date of publication of the European application | 2011-02-09 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/041981 |
| Date | 2009-04-28 |
| (87) | Number | WO 2009/134805 |
| Date | 2009-11-05 |
| (30) | Number | Date | Country code |
| 48522 | 2008-04-28 | US |
| (72) |
BEBBINGTON, Christopher, R., US
LUEHRSEN, Kenneth, US
YARRANTON, Geoffrey, T., US
|
| (73) |
Humanigen, Inc.,
533 Airport Boulevard Suite 400, Burlingame, CA 94010,
US
|
| (54) | ANTIBODIES TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR |
| ANTIBODIES TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR |